Novel Oral Agents in Obesity Management: Efficacy, Tolerability, and Adherence

Novel Oral Agents in Obesity Management: Efficacy, Tolerability, and Adherence

Click Here to Register 

Details:

  • Date: December 1, 2026
  • Time: 7:00 - 8:00 PM Eastern Time
  • Location: Online Webinar

Join us to explore the evolving landscape of oral obesity therapies, key clinical evidence and their potential role in Canadian primary care. Gain practical insights from U.S. clinical experience through expert discussion and live Q&A addressing questions submitted in advance by HCPs. To learn more or register, click here or contact obesitymgmt [at] eocihealth.com (obesitymgmt[at]eocihealth[dot]com)

Learning Objectives:

​By the end of this program, participants will be able to:

  1. Describe the current and emerging landscape of oral obesity management medications and the key clinical trial evidence supporting their use.
  2. Discuss where oral obesity management medications may fit within the current Canadian landscape.
  3. Apply practical, real-world insights from U.S. clinical experience

Faculty:

Alice Cheng

MD, FRCPC

Endocrinologist

Toronto, ON 

Rodolfo J. Galindo

MD

Endocrinologist

Miami, FL, USA

James W. Kim

MBBCh, PgDip, MScCH(HPTE), CPC(HC)  

Family Physician

Calgary, AB